D. E. Schwartz

1.1k total citations
28 papers, 872 citations indexed

About

D. E. Schwartz is a scholar working on Molecular Biology, Pharmacology and Spectroscopy. According to data from OpenAlex, D. E. Schwartz has authored 28 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Spectroscopy. Recurrent topics in D. E. Schwartz's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Analytical Chemistry and Chromatography (4 papers) and Cancer therapeutics and mechanisms (4 papers). D. E. Schwartz is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Analytical Chemistry and Chromatography (4 papers) and Cancer therapeutics and mechanisms (4 papers). D. E. Schwartz collaborates with scholars based in Switzerland, United States and Zambia. D. E. Schwartz's co-authors include F Jeunet, Bernard J. Moncla, K Dix, Robert E. Weinfeld, Shiro Watanabe, Bernard A. Koechlin, Walter Vetter, J. Rieder, J Raaflaub and D Richard-Lenoble and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Microbiology and Cellular and Molecular Life Sciences.

In The Last Decade

D. E. Schwartz

28 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. E. Schwartz Switzerland 16 286 178 176 146 133 28 872
Thomas O. Frommel United States 18 233 0.8× 133 0.7× 53 0.3× 225 1.5× 298 2.2× 30 898
Robert L. Smith United States 15 81 0.3× 32 0.2× 75 0.4× 136 0.9× 310 2.3× 27 958
M. Hedberg Sweden 20 214 0.7× 169 0.9× 135 0.8× 217 1.5× 225 1.7× 34 1.2k
Vesna Munić Kos Sweden 17 73 0.3× 26 0.1× 112 0.6× 266 1.8× 259 1.9× 35 1.1k
A. P. Ball United Kingdom 17 87 0.3× 12 0.1× 253 1.4× 260 1.8× 127 1.0× 41 857
Hitomi Yamada Japan 15 63 0.2× 284 1.6× 39 0.2× 86 0.6× 371 2.8× 40 1.2k
Nicole Houdret France 20 153 0.5× 11 0.1× 86 0.5× 117 0.8× 707 5.3× 58 1.5k
Pooja Agarwal India 14 140 0.5× 62 0.3× 19 0.1× 77 0.5× 128 1.0× 39 589
HJ Rogers United Kingdom 21 98 0.3× 5 0.0× 197 1.1× 55 0.4× 262 2.0× 38 948
R. S. Griffith United States 20 53 0.2× 7 0.0× 305 1.7× 255 1.7× 180 1.4× 35 1.0k

Countries citing papers authored by D. E. Schwartz

Since Specialization
Citations

This map shows the geographic impact of D. E. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. E. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. E. Schwartz more than expected).

Fields of papers citing papers by D. E. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. E. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. E. Schwartz. The network helps show where D. E. Schwartz may publish in the future.

Co-authorship network of co-authors of D. E. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of D. E. Schwartz. A scholar is included among the top collaborators of D. E. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. E. Schwartz. D. E. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moncla, Bernard J., Pamela H. Braham, K Dix, Shiro Watanabe, & D. E. Schwartz. (1990). Use of synthetic oligonucleotide DNA probes for the identification of Bacteroides gingivalis. Journal of Clinical Microbiology. 28(2). 324–327. 63 indexed citations
2.
Schwartz, D. E., E. Weidekamm, I Mimica, P. Heizmann, & Renée Portmann. (1987). Multiple-Dose Pharmacokinetics of the Antimalarial Drug Fansimef® (Pyrimethamine + Sulfadoxine + Mefloquine) in Healthy Subjects. Chemotherapy. 33(1). 1–8. 18 indexed citations
3.
Schwartz, D. E., et al.. (1987). Urinary Excretion of Mefloquine and Some of Its Metabolites in African Volunteers at Steady State. Chemotherapy. 33(5). 305–308. 6 indexed citations
4.
Souza, José Maria de, P. Heizmann, & D. E. Schwartz. (1987). Single-dose kinetics of mefloquine in Brazilian male subjects.. PubMed. 65(3). 353–6. 14 indexed citations
5.
Weidekamm, E., D. E. Schwartz, U. C. Dubach, & Brandon Weber. (1987). Single-Dose Investigation of Possible Interactions between the Components of the Antimalarial Combination Fansimef®. Chemotherapy. 33(4). 259–265. 16 indexed citations
6.
Looareesuwan, S., et al.. (1987). Studies of mefloquine bioavailability and kinetics using a stable isotope technique: a comparison of Thai patients with falciparum malaria and healthy Caucasian volunteers.. British Journal of Clinical Pharmacology. 24(1). 37–42. 50 indexed citations
7.
Schwartz, D. E., et al.. (1982). Single Dose Kinetics of Mefloquine in Man. Chemotherapy. 28(1). 70–84. 58 indexed citations
8.
Schwartz, D. E., et al.. (1981). Highly sensitive and specific determination of mefloquine in biological fluids using gas chromatography mass spectrometry with selected ion monitoring. Journal of Mass Spectrometry. 8(12). 589–592. 20 indexed citations
9.
Schwartz, D. E., Willi Weber, D Richard-Lenoble, & M Gentilini. (1980). Kinetic studies of mefloquine and of one of its metabolites, Ro 21-5104, in the dog and in man.. PubMed. 37(3). 238–42. 26 indexed citations
10.
Schwartz, D. E., Alberto Frigerio, & Malcolm McCamish. (1980). Quantitative determination of the antimalarial drug mefloquine and of its main metabolite in plasma by direct densitometric measurement on thin-layer chromatographic plates.. 69–74. 2 indexed citations
11.
Schwartz, D. E., et al.. (1979). Metabolic Studies of Ornidazole in the Rat, in the Dog and in Man. Xenobiotica. 9(9). 571–581. 39 indexed citations
12.
Schwartz, D. E. & Roger D. Brandt. (1978). Pharmacokinetic and metabolic studies of the decarboxylase inhibitor benserazide in animals and man.. PubMed. 28(2). 302–7. 14 indexed citations
13.
Schwartz, D. E. & F Jeunet. (1976). Comparative Pharmacokinetic Studies of Ornidazole and Metronidazole in Man. Chemotherapy. 22(1). 19–29. 91 indexed citations
14.
Rieder, J., et al.. (1974). �bergang von Sulfamethoxazol und Trimethoprim in das Augenkammerwasser beim Menschen. Graefe s Archive for Clinical and Experimental Ophthalmology. 190(1). 51–61. 2 indexed citations
15.
Schwartz, D. E. & P. T. Gilham. (1972). Sequence analysis of polyribonucleotides by stepwise chemical degradation. Method for the introduction of radioactive label into nucleoside fragments after cleavage. Journal of the American Chemical Society. 94(25). 8921–8922. 12 indexed citations
16.
Schwartz, D. E., Walter Vetter, & Gerhard Englert. (1970). Trimethoprim metabolites in rat, dog and man: qualitative and quantitative studies.. PubMed. 20(12). 1867–71. 46 indexed citations
17.
Schwartz, D. E., Bernard A. Koechlin, & Robert E. Weinfeld. (1969). Spectrofluorimetric Method for the Determination of Trimethoprim in Body Fluids. Chemotherapy. 14(1). 22–29. 95 indexed citations
18.
Schwartz, D. E., H. Bruderer, J. Rieder, & A. BROSSI. (1964). Metabolic studies of Versidyne, a new analgesic, in the rabbit and in man. Biochemical Pharmacology. 13(5). 777–778. 9 indexed citations
19.
Grasset, E. & D. E. Schwartz. (1955). IN VIVO AND IN VITRO COMPARATIVE ASSAYS OF THE ANTICOAGULANT ACTIVITY OF DEXTRAN SULPHATE AND HEPARIN. British Journal of Pharmacology and Chemotherapy. 10(3). 317–320. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas O. Frommel Breakdown of academic impact, for papers by Robert L. Smith Breakdown of academic impact, for papers by M. Hedberg Breakdown of academic impact, for papers by Vesna Munić Kos Breakdown of academic impact, for papers by A. P. Ball Breakdown of academic impact, for papers by Hitomi Yamada Breakdown of academic impact, for papers by Nicole Houdret Breakdown of academic impact, for papers by Pooja Agarwal Breakdown of academic impact, for papers by HJ Rogers Breakdown of academic impact, for papers by R. S. Griffith
Rankless by CCL
2026